Covaxin gets shelf life extension up to 12 months
The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of the shelf life of India's indigenously developed COVID-19 vaccine -- Covaxin -- up to 12 months from the date of manufacture, Bharat Biotech said on Wednesday.
In a tweet, Bharat Biotech said, "The CDSCO has approved the extension of shelf life of Covaxin up to 12 months, from the date of manufacture. This approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO."
The shelf life extension has been communicated to "our stakeholders," it added.
(with PTI inputs)
ALSO READ: Bharat Biotech's Covaxin added to approved list of COVID vaccines for travel to Australia
ALSO READ: Bharat Biotech submitting data on Covaxin 'very quickly', trust Indian industry: WHO
